ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

Arndt Vogel

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

Flavio Rocha

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

UChicago Medicine

A. A. Pillai

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

Cholangiocarcinoma Updates

Houston Methodist

M. Javle

ESMO 2024 Summary: IDH Mutated Cholangiocarcinoma - Diagnostic and T…

2024 ESMO Annual Meeting Insights Hub

T. Macarulla Mercade

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -03 Cl…

Insights from 2023 ESMO Annual Meeting

A. Lamarca

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Class?"

Insights from 2023 ASCO® Annual Meeting

A. Vogel

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR Inhibit…

Insights from 2023 ESMO Annual Meeting

M. Pelster

Management of Hepatocellular Carcinoma & Cholangiocarcinoma - Role o…

Houston Methodist

A. O. Kaseb

Cholangiocarcinoma: Disease Overview, Diagnosis, and Treatment Optio…

MedNews Week

J. Cleary

Treatment Algorithm Series: Management of Advanced Cholangiocarcinoma

Richard Kim

A. Mahipal

The Role of Liver Transplantation in Cholangiocarcinoma

Stanford Medicine

T. Tara Ghaziani

Evolving Epidemiology of Hepatocellular Cancer & Cholangiocarcinoma

Houston Methodist

A. Connor

Year in Review: Hepato-Biliary Surgical Oncology

OncoAlert

S. Conci

ASCO GI 2022 Updates on Integrating New Targeted Therapy Into Locore…

ASCO GI 2022 Conference Coverage

F. Rocha

Immunotherapy for Cholangiocarcinoma

Nicola Personeni

Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Curre…

Houston Methodist

A. Connor, A. O. Kaseb, S. Kodali